17 August 2021
SARS-CoV-2 Variant Analysis Portfolio Expanded
SpeeDx have expanded their product line of research reagents for COVID-19 variant analysis to include a mutation connected to the SARS-CoV-2 Delta variant of concern (VOC), P681R. The recently launched PlexPrime® SARS-CoV-2 Genotyping* product line utilises unique universal substrates and patented multiplexing technology to offer a streamlined solution to labs seeking to identify key VOCs in their positive SARS-CoV-2 sample population. PlexPrime® SARS-CoV-2 P681R Delta* is a single well mix designed to detect the P681R spike mutation of SARS-CoV-2 found in B1.617.2 (Delta) VOC1, in addition to an RdRp gene target of SARS-CoV-2.
Read the press release